Get started
Work

Supplementary Tables S1-S26 from A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic Cancer

Year: 2023
Type: supplementary-materials
Abstract: Tables S1-S26. Includes details of antibodies, shRNAs and sgRNAs used in this study. CRISPR and drug screening data.
DOI: 10.1158/1535-7163.22521181
Authors: Charlotte K. Milton, Annette J. Self, Paul A. Clarke, Udai Banerji, Federica Piccioni, David E. Root, Steven R. Whittaker
Language: English
Open Access status: gold
OpenAlex ID: W4362537629
Cites:
Cited by:
Related to: 10